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Cardiac arrest and sudden death in dialysis units. mon cause of death, with nearly half of deaths attributed
Background. For patients with end-stage renal disease and to myocardial infarction, cardiac arrest, or other cardiac
their providers, dialysis unit-based cardiac arrest is the most causes [2]. Numerous studies have looked at predictorsfeared complication of hemodialysis. However, relatively little
of cardiac mortality in maintenance hemodialysis pa-is known regarding its frequency or epidemiology, or whether
tients. A history of ischemic heart disease, congestivea fraction of these events could be prevented.
Methods. To explore clinical correlates of dialysis unit-based heart failure, left ventricular hypertrophy (LVH) and dys-
cardiac arrest, 400 reported arrests over a nine-month period function, peripheral vascular disease, hypertension or hy-
from October 1998 through June 1999 were reviewed in detail. potension, hypoalbuminemia, dyslipidemia, anemia, andClinical characteristics of patients who suffered cardiac arrest
inflammation (elevated C-reactive protein) have all beenwere compared with a nationally representative cohort of
associated with increased cardiovascular mortality [3–9].77,000 hemodialysis patients dialyzed at Fresenius Medical
Care North America-affiliated facilities. Using data from the U.S. Renal Data System Case
Results. The cardiac arrest rate was 400 out of 5,744,708, Mix Adequacy Study, Bleyer, Russell, and Satko docu-
corresponding to a rate of 7 per 100,000 hemodialysis sessions.
mented a significantly higher proportion of suddenCardiac arrest was more frequent during Monday dialysis ses-
deaths in hemodialysis patients on Monday and Tuesdaysions than on other days of the week. Case patients were nearly
twice as likely to have been dialyzed against a 0 or 1.0 mEq/L compared with other days of the week [10]. No other
potassium dialysate on the day of cardiac arrest (17.1 vs. 8.8%). risk factors for sudden death were identified. The authors
Patients who suffered a cardiac arrest were on average older postulated that the accumulation of electrolytes and flu-(66.3 12.9 vs. 60.2 15.4 years), more likely to have diabetes
ids between dialysis sessions increased the susceptibility(61.8 vs. 46.8%), and more likely to use a catheter for vascular
to arrhythmias, especially after a weekend respite fromaccess (34.1 vs. 27.8%) than the general hemodialysis popula-
tion. Sixteen percent of patients experienced a drop in systolic dialysis. No data were available on the timing of sudden
pressure of 30 mm Hg or more prior to the arrest. Thirty- death relative to the hemodialysis session. Presumably,
seven percent of patients who suffered cardiac arrest had been
the majority of sudden death cases occurred at homehospitalized within the past 30 days. Sixty percent of patients
rather than during dialysis.died within 48 hours of the arrest, including 13% while in the
dialysis unit. Relatively few studies have examined the epidemiol-
Conclusions. Cardiac arrest is a relatively infrequent but ogy of in-dialysis unit cardiac arrest. Moreover, no prior
devastating complication of hemodialysis. To reduce the risk investigation has had sufficient power to estimate its in-
of adverse cardiac events on hemodialysis, the dialysate pre-
cidence accurately or to identify patient- and hemodialy-scription should be evaluated and modified on an ongoing
sis-specific factors that might be associated with a higherbasis, especially following hospitalization in high-risk patients.
than baseline risk. We therefore undertook this study of
cardiac arrest during hemodialysis using data obtained
directly from dialysis units at the time of the event. WeHemodialysis patients have an age-adjusted mortality
were most interested in identifying modifiable risk fac-rate that is 3.5 times higher than that of the general pop-
ulation [1]. Cardiovascular disease remains the most com- tors so that some future events might be prevented.
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myocardial infarction, CABG, FMCNA population, mortality in HD.
Patients
Received for publication October 12, 2000
Patients who had a cardiac arrest while in the dialy-and in revised form January 6, 2001
Accepted for publication February 13, 2001 sis facility were identified by Clinical Variance (Adverse
Event) Reports (CVR) written by Fresenius Medical 2001 by the International Society of Nephrology
350
Karnik et al: Cardiac arrest in dialysis units 351
Care North America (FMCNA) dialysis unit personnel. with the Student t test, analysis of variance (ANOVA),
or the Wilcoxon rank sum test where appropriate. Pair-Facility staff completed an additional “event-specific”
data form for in-dialysis unit cardiac arrest. There were wise comparisons in ANOVA were performed using the
Student–Newman–Keuls procedure. Categorical vari-401 CVRs and cardiac arrest data forms reviewed from
the nine-month period of October 1998 through June ables were described using proportions and analyzed
using the 2 test. To test whether cardiac arrest was more1999. Dialysis run sheets were additionally available in
the vast majority of patients. Of the 401 cases reviewed, or less likely by days of the week, a two-tailed binomial
test was performed. Logistic regression analysis was used1 (0.3%) was excluded from the final study sample because
of missing clinical data for the majority of variables. to identify independent predictors of early fatal cardiac
arrest. Odds ratios and 95% confidence limits were calcu-
Study design lated from model parameter coefficients and standard
errors, respectively. When comparing case patients withWe used a case-cohort study approach to compare the
400 cardiac arrest cases with the population of hemodial- the FMCNA cohort, two-tailed P values 0.01 were con-
sidered significant, given the large cohort size and multipleysis patients cared for at FMCNA facilities during the
study period. Data were abstracted from the CVR and car- comparisons of demographic and laboratory variables.
When conducting analyses among cases alone, a signifi-diac arrest data forms by a single investigator (J.A.K.).
Information on age, gender, race or ethnicity, date of cance criterion of P  0.05 was applied. Data were ini-
tially entered on an Excel spreadsheet (Microsoft, Red-event, last hospitalization, do not resuscitate (DNR) sta-
tus, and location of the event were taken directly from mond, WA, USA) and analyzed using SAS 7.0 (SAS
Institute, Cary, NC, USA). Figures were constructed us-the reports. Past medical history and medication use
were recorded from information included on the CVR ing Sigma Plot 2000 (SPSS Inc., Chicago, IL, USA).
and cardiac arrest data forms or on accompanying medi-
cal records and ICD-9 codes. Information regarding the
RESULTS
type of arrhythmia, associated symptoms if any, and vital
Incidence ratesigns prior to the cardiac arrest were abstracted from
the CVR, cardiac arrest data forms, dialysis run sheets, There were 400 documented cardiac arrests among
the 5,744,708 hemodialysis treatments provided duringincident reports, and code sheets, where applicable. No-
menclature was based on the Utstein style, the recom- the nine-month study period. This corresponds to an
incidence rate of 0.007% (or 7 per 100,000).mended guidelines for uniform reporting of data from
out-of-hospital cardiac arrest [11].
Utstein-style templateA diagnosis of coronary artery disease included either
a clinical diagnosis of cardiovascular disease (for exam- By definition, all cardiac arrests were in the dialysis
unit and therefore “witnessed.” Of the 400 cardiac ar-ple, myocardial infarction and angina) or a coronary
angiography report. Components of the dialysis prescrip- rests, 386 were presumed to be of cardiac etiology. There
were 14 (3.5%) suspected noncardiac causes of cardiaction, including the full composition of dialysate, were
available on the vast majority of patients, as these were arrest. These included seven patients with seizure activ-
ity, three with suspected respiratory arrest caused byrecorded on the dialysis run sheets. Medication lists,
smoking history, and information on adherence with di- aspiration, three with suspected drug allergies, two falls
(one with a documented subdural hematoma), and onealysis or medications were available in relatively few
patients and could not be reliably evaluated. Recent suspected pulmonary embolism. An abnormal rhythm
was documented in 66 (16.5%) patients. We were unable(“monthly”) laboratory values were obtained from the
CVR, cardiac arrest data forms, and the dialysis run to independently confirm these findings by review of
electrocardiograms. Among the 66 patients with a docu-sheets. In cases of death associated with cardiac arrest,
autopsy reports and other detailed descriptions were not mented arrhythmias, 28 (42.4%) had ventricular fibrilla-
tion, while 13 (19.7%) had ventricular tachycardia and 10routinely available. Where there were no responses to a
full series of inquiries on a specific form, blank responses (15.2%) were initially asystolic. Forty percent of patients
survived the initial event. Of the 60% who died withinwere deemed “missing.” Otherwise, isolated nonre-
sponses (for example, blank history of “Y” following an 48 hours of the arrest, 13% died in the dialysis unit, and
the remaining 47% died en route or in the hospital.affirmative history of “X”) were assumed to be negative.
Data were generally missing in fewer than 5 to 10% of Longer-term outcomes were not available.
CVRs and cardiac arrest data forms.
Patient (“case”) characteristics
Statistical analysis Demographics and history. The mean age was 66.3
years, which was significantly higher than the age ofContinuous variables were described as mean  SD
or median with interquartile range and were analyzed FMCNA cohort (P  0.0001). Of the case patients,
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Table 1. Patient characteristics (non-laboratory)27.7% were 75 years and 4.6% were 85 years of
age. Nearly half (48.5%) were female. The majority of Cardiac arrest FMCNA
patients (53%) were white, 39.3% were African Ameri- Characteristic %
can, 5.7% were Hispanic, 1.5% were Asian, and 0.7%
Agea years 66.312.9 60.215.4
were of other races or ethnicities. Mean dialysis vintage Sex % female 48.5 47.5
Race or ethnicitywas 29.0 months (median 15 months, interquartile range
African American 39.3 38.3of 4 to 39 months). The prevalence of diabetes was 61.8%
Caucasian 52.7 54.7
(49.0% type II and 12.8% type I), compared with 46.8% Hispanic 5.7 16.0d
Asian 1.5 1.3(42.7% type II and 4.1% type I) in the FMCNA cohort
Other or unknown 0.7 5.7(P  0.001). Case patients were more likely to use a
Diabetesa
catheter for vascular access (34.1 vs. 27.8%, P  0.01). Type I 12.8 4.1
Type II 49.0 42.7Nearly half (48%) of patients had a history of coronary
Vascular accessbartery disease (CAD). Twenty-four percent had a history
AV fistula 14.5 22.7
of myocardial infarction (MI), and 12% a history of AV graft 51.4 49.3
Tunneled catheter 20.4coronary artery bypass surgery (CABG). There was a
Percutaneous (temporary) catheter 13.7 27.8history of pacemaker placement in 9% of patients; only
History of MI 24.1 NA
one patient (0.3%) had an automated implantable con- History of CABG 12.1 NA
History of PVD 25.9 NAtrolled defibrillator (AICD). Table 1 outlines additional
History of stroke 11.8 NAvariables of interest in case and (where available) cohort
History of arrhythmiac 28.0 NA
populations. History of pacemaker 8.7 NA
History of non-cardiac diseases NALaboratory values. Table 2 outlines recent laboratory
Gastrointestinal 16.7values in case patients and the FMCNA cohort. There
Neurologic (non-CVA) 14.9
were small but significant differences in several labora- Pulmonary 12.9
Cancer or related disease 10.2tory parameters; arguably, the most important were
Endocrine (non-DM) 6.2lower levels of serum albumin, creatinine, and hemoglo-
Rheumatologic 6.0
bin, the three laboratory variables most consistently and Infectious 4.5
Do not resuscitate order present 7.0 NAstrongly associated with overall mortality in the hemodi-
Hospitalization within past 30 days 37.1 NAalysis population. Serum albumin and creatinine concen-
Hospitalization within past 30 days for
trations were lower than expected, even after accounting cardiac cause 12.9 NA
for the older age of case patients. Also noteworthy was Abbreviations are: FMCNA, Fresenius Medical Care of North America; AV,
arteriovenous; MI, myocardial infarction; CABG, coronary artery bypass graft;the mean urea reduction ratio (URR; 69.5% in cases
PVD, peripheral vascular disease; CVA, cardiovascular arrhythmia; DM, diabe-and 69.7% in cohort, P  0.70), indicating that the dose tes mellitus; NA, not available.
a P  0.001of dialysis was not significantly lower in patients who
b FMCNA does not distinguish between temporary (percutaneous) and tun-had suffered cardiac arrest. neled catheters. The percentage of all catheters was 34.1% in cardiac arrest cases
and 27.8% in FMCNA cohort, P  0.01Dialysis prescription. Zero or 1.0 mEq/L potassium
c One of the following: atrial fibrillation, atrial flutter, Wolf-Parkinson-White,baths were prescribed for 17.1% of case patients, com- supraventricular tachycardia, bradycardia, sick sinus syndrome, first degree heart
block, trifascicular block, unspecified heart block, left bundle branch block, rightpared with only 8.8% of patients in the FMCNA cohort
bundle branch block, unspecified ventricular arrhythmia, ventricular tachycardia,(P  0.0001). The increased usage of low potassium ventricular fibrillation
d FMCNA reports ethnicity independent of racedialysate in the case patients could not be explained
by higher predialysis potassium values (mean potassium
4.78 vs. 4.90 mEq/L in FMCNA cohort, P  0.01).
Among the patients prescribed 0 or 1.0 mEq/L dialysate
tration also was plotted against serum potassium andpotassium, 16.9% had predialysis serum potassium con-
calcium concentrations in Figures 2 and 3. While infor-centrations 4.0 mEq/L. Just 17.8% of patients pre-
mation on dialysate bicarbonate was available on fewerscribed a 0 or 1.0 mEq/L dialysate potassium had a pre-
case patients, Figures 2 and 3 show that several individu-dialysis serum potassium5.0 mEq/L, and only 4% were
als were dialyzed on high bicarbonate baths (37 mEq/L6.0 mEq/L. Dialysate potassium concentrations of
or above) with relatively low predialysis serum potas-3.0 mEq/L were prescribed for 12.3% of case patients
sium and calcium concentrations.and 12.3% of the FMCNA cohort. Figure 1 shows the
Day and time of arrest. Ninety-three cardiac arrestsrelationship between the last measured predialysis serum
were on Mondays compared with 54 on Wednesdayspotassium and the prescribed dialysate potassium con-
(P  0.001) and 58 on Fridays (P  0.004). There wascentrations. Since correction of acidosis will lower the
no day-of-the-week effect for patients on a Tuesday-serum concentrations of potassium and calcium (pro-
Thursday-Saturday schedule. The number of cardiac ar-longing the QT interval and increasing the risk of certain
cardiac arrhythmias), the dialysate bicarbonate concen- rests was only slightly higher on Tuesdays (N  65) and
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Table 2. Laboratory values in case patients and FMCNA population (systolic blood pressure 100 mm Hg). Sixteen percent
of patients experienced treatment-induced hypotensionLaboratory parameter Cardiac arrest FMCNA
(arbitrarily defined as a drop in systolic blood pressureSodium mEq/L 137.14.5 137.83.5
Potassium mEq/L 4.780.94 4.900.71 of 30 mm Hg during treatment) before the arrest.
Bicarbonatea mEq/L 20.714.37 19.893.07
Calciumc mg/dL 9.041.00 9.010.81 Treatment and outcomes
Phosphorusd mg/dL 5.261.87 5.681.66
Urea nitrogena mg/dL 54.119.4 57.517.2 Hypertonic agents (hypertonic saline, mannitol, and
Creatinined mg/dL 7.282.53 7.973.42 50% dextrose) were administered to 11% of patients
Albumind g/dL 3.530.56 3.680.48
before the onset of the arrest. There was no differenceURRc % 69.510.2 69.78.0
Hemoglobina g/dL 10.61.6 10.91.2 in mean predialysis serum potassium (P  0.73), the
Parathyroid hormone proportion of patients with hyperkalemia (6.0 mEq/L,
pg/mL 142 (56.3 to 296.2) 157.7 (73.4 to 313.0)
P 0.96), or the dialysate potassium concentration (P
Parathyroid hormone (PTH) is presented as median (interquartile range), no 0.95) in patients given or not given hypertonic agents.inference test conducted.
a P  0.001 No other drugs were given in more than 5% of patients.
b P  0.01 As noted previously in this article (Utstein template),c No significant difference (P  0.70 for URR, P  0.55 for calcium compari-
sons) 40% of patients were successfully resuscitated and were
d P  0.0001 still alive after two days. Male gender (OR 2.3, 95% CI,
1.5 to 3.5) and diabetes (OR 1.5, 95% CI, 1.0 to 2.3)
were correlates of early fatal cardiac arrest. Among indi-
viduals whose arrhythmia type was documented (ventric-Saturdays (N 68) than on Thursdays (N 57, P 0.47
and P  0.33, respectively). There were no significant ular fibrillation, ventricular tachycardia, asystole, or
other), there was no significant difference in short-termdifferences in the distribution of patient characteristics
among those who arrested on Monday versus any other mortality by rhythm type (P  0.40).
day (data not shown).
Seven percent of events occurred immediately before,
DISCUSSION
81% during, and 12% following dialysis but prior to
Hemodialysis patients are at an increased risk forleaving the facility. The mean time into dialysis at which
cardiac arrest and sudden death relative to the generalthe cardiac arrest occurred was 123  77 minutes. Pa-
population. Numerous factors have been proposed totients dialyzed with a 0 or 1.0 mEq/L potassium dialysate
increase the risk of cardiovascular disease (including sud-arrested later in the course of dialysis (172 and 141 min,
den death) in end-stage renal disease (ESRD), includingrespectively) than patients on a 2.0 or 3.0 mEq/L potas-
atherosclerotic disease, autonomic dysfunction, hyperco-sium dialysate (119 and 120 min, respectively, P 0.01).
agulability, hypertension, left ventriculary hypertrophyThere was no significant association between the predial-
(LVH) and dysfunction, volume overload, hemodynamicysis serum potassium and the timing of the arrest. There
instability, anemia, dyslipidemia, hyperhomocysteinemia,was a significant association between access type and the
in situ cardiac and coronary artery calcification, inflam-timing of the arrest (P  0.007), as the mean time to
mation, and a variety of common metabolic disturbancesarrest was shorter among patients with temporary cathe-
(including hyperkalemia, hypocalcemia and hypercalce-ters (mean 88 min) than for patients with arteriovenous
mia, hyperphosphatemia, and hyperparathyroidism) [3–9,grafts (mean 135 min) or arteriovenous fistulas (mean
12–19]. Given the prevalence and severity of traditional129 min). There was no association between the predial-
cardiovascular risk factors in ESRD, along with uniqueysis potassium concentration and access type (P 0.26).
dialysis-specific stressors, it is not surprising that half ofTime to the arrest was significantly longer in patients
all hemodialysis-related deaths are due to cardiovascularwith a history of coronary artery disease (mean 132 vs.
disease, with a cause-specific mortality rate that exceeds114 min, P 0.03) and was significantly longer in women
the general population’s by more than an order of magni-compared with men (mean 133 vs. 115 min, P  0.03).
tude [20]. Cardiac arrest is reported to account for ap-There was no significant difference in the timing of arrest
proximately one third of all cardiac deaths in hemodialy-by age, race, diabetes, or history of arrhythmia.
sis patients [2].
Symptoms and problems In this case-cohort study, we found that patients who
suffered an in-facility cardiac arrest were older, moreTable 3 outlines the most common symptoms preced-
likely to have diabetes, and more likely to be using aing arrest, which were dyspnea and other nonspecific
catheter for vascular access. A large fraction of casecomplaints. The vast majority of patients had no overt
patients was recently hospitalized. Nearly half had a his-symptoms preceding the arrest. Two percent of patients
tory of coronary artery disease, and one in six experi-were severely hypertensive (systolic blood pressure200
mm Hg) at the start of dialysis; 23% were hypotensive enced a large (30 mm Hg) drop in systolic blood pres-
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Fig. 1. Dialysate potassium concentration (in
mEq/L) versus most recent predialysis serum
potassium (in mEq/L). Symbol is: () dialy-
sate K vs. patient K.
Fig. 2. Dialysate bicarbonate concentration
(in mEq/L) versus most recent predialysis se-
rum potassium (in mEq/L). Symbol is: ()
dialysate HCO3 vs. patient K.
sure before the arrest. There was no association between hemodialysis has been reported to range from 18 to 76%.
Age over 55 years, impaired left ventricular function,gender or race and cardiac arrest, even though men and
Caucasians have a higher risk of ischemic heart disease LVH, systolic hypertension, increased concentrations of
calcium, phosphorus, and parathyroid hormone, digoxinthan women or African Americans, respectively, in both
the general population and persons with ESRD [20]. use, acetate-based dialysate, and the use of cuprophan
dialyzers have been identified as potential risk factorsSeveral studies have identified the relative frequency
and correlates of ventricular ectopic activity (VEA) dur- for VEA. Despite the wealth of information regarding
VEA during dialysis, no study has demonstrated an asso-ing hemodialysis [21–29]. Depending on the study and
the definition of VEA, the incidence of VEA during ciation between hemodialysis-related VEA and sudden
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Fig. 3. Dialysate bicarbonate concentration
(in mEq/L) versus most recent predialysis se-
rum calcium (in mg/dL). Symbol is: () dialy-
sate HCO3 vs. patient Ca.
Table 3. Symptoms preceding cardiac arrest was the most recent serum potassium 5.0 mEq/L. In
addition to the development of dialysis-induced hypoka-Symptom %
lemia, more subtle metabolic abnormalities might alsoDyspnea 11
Feeling “sick” or “bad” 7 place patients at increased risk of arrhythmia. For exam-
Nausea 6 ple, patients with hypocalcemia or hypomagnesemia
Chest pain 5
could develop VEA due to QT dispersion (for example,“Dizzy” 4
Vomiting 4 torsade de pointes) [30], either because of low (2.5 mEq/L
Abdominal pain 2 or less) dialysate calcium concentrations or the intracellu-
lar shifting of potassium with dialysis-related increases in
pH, even in the absence of frank hypokalemia predialysis.
Few studies have carefully examined cardiac arrest
cardiac death, either during dialysis or at home. An Ital-
and sudden death in dialysis patients. Moss, Holley, andian study followed patients with VEA for four years and
Upton reported on the health status of 221 ESRD pa-found that only age and ischemic heart disease were
tients who suffered cardiac arrests (not exclusively dur-associated with mortality, rather than VEA [29].
ing dialysis) [31]. Seventy-four (34%) underwent cardio-The timing of the arrest may yield some insights into
pulmonary resuscitation (CPR); six of 64 (8%) survivedthe mechanism(s) underlying respective events. It is
to hospital discharge, and only two (3%) were alive sixnoteworthy that patients dialyzed on a 0 or 1.0 mEq/L
months later. Using data from a University-affiliated di-potassium bath arrested later in the course of dialysis
alysis program in Taiwan, Lai, Hung and Tsai describedthan patients dialyzed on a 2.0 or 3.0 mEq/L or higher
24 cases of cardiac arrest during hemodialysis, corre-potassium bath. Munger et al recently showed a twofold
sponding to a rate of 0.08% (1 per 1237 treatments) [32].increase in the incidence of silent ischemia during the
Eleven of the 24 cases had ESRD, and others were pa-latter half of a four-hour hemodialysis session [28]. In the
tients receiving dialysis for acute renal failure. All pa-Munger et al study, supraventricular ectopy increased
tients underwent cardiopulmonary resuscitation (CPR).steadily over time. Although the dialysate potassium con-
Six (25%) CPR attempts were unsuccessful. Sevencentration has not conclusively been implicated as causing
(29.2%) patients survived CPR but died within 24 hours,cardiac arrest, Morrison et al demonstrated decreased
and only one (4.2%) patient was alive six months later.VEA in four of six patients whose dialysate potassium
There are several important limitations to this study.concentration was changed from 2.0 to 3.5 mEq/L [21].
First, we were unable to verify certain elements of clinicalAmong the 400 case patients presented here, 17.8%
data from the FMCNA hemodialysis cohort, includingwere dialyzed against a low dialysate potassium concen-
tration (0 or 1.0 mEq/L), and in fewer than one in five time since last hospitalization and the frequency of co-
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morbid conditions, so that the frequency of these risk ACKNOWLEDGMENT
factors could not be directly compared with the patients The work was accepted for presentation in abstract form at the
33rd Annual Meeting of the American Society of Nephrology, Octoberwho suffered cardiac arrest. Second, medication use was
2000, Toronto, Ontario, Canada.not well documented by the CVR process. While it is
theoretically possible that digoxin, type Ia and other Reprint requests to Glenn M. Chertow, M.D., Division of Nephrol-
ogy, University of California, San Francisco, 672 Health Sciences East,antiarrhythmic agents, antihypertensive agents, or other
San Francisco, California 94143-0532, USA.drugs might promote VEA in hemodialysis patients, we E-mail: chertowg@medicine.ucsf.edu
were unable to determine any associations between med-
ication use and the risk of cardiac arrest. Third, labora-
APPENDIXtory data, including potassium, calcium, and bicarbonate
Abbreviations used in this article are: AICD, automated implantale-concentrations were the “most recent available” and may
controlled defibrillator; AV, arteriovenous; CABG, coronary arterynot have reflected the serum values immediately predial- bypass graft; CPR, cardiopulmonary resuscitation; CRP, C-reactive
ysis. Misclassification of hyperkalemia or hypokalemia, protein; CVA, cardiovascular arrhythmia; CVR, Clinical Variance
(Adverse Event) Reports; DM, diabetes mellitus; DNR, do not resusci-for example, would likely bias the association between
tate; FMCNA, Fresenius Medical Care of North America; LVH, leftpredialysis serum potassium level (as determined here) ventricular hypertrophy; MI, myocardial infarction; PTH, parathyroid
hormone; PVD, pulmonary vascular disease; URR, urea reductionand arrest toward the null. Finally, while the CVR and
ratio; VEA, ventricular ectopic activity.cardiac arrest data forms included considerable detail
regarding the dialysis procedure and events preceding
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